Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Favrille (FVRL)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: FVRL
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Failure to Launch for Last Year's Big Pharma and Biotech Hopes
EP Vantage
•
Feb 13
•
Comment!
Russian Roulette Pays Off for Antigenics
Mike Huckman
•
Apr 09
•
5 Comments
A Triple Catalyst Biotech Play
Mike Havrilla
•
Dec 17
•
2 Comments
Biotech Day In Review: Osiris Stem Cells Treatment Has Unexpected Results
Centient Biotech Investor
•
Feb 15
•
Comment!
Favrille Investors: Wait Patiently For Final Phase III Results
Jason Shade
•
Nov 27
•
Comment!
More articles on FVRL »
Latest Transcript
Favrille Inc. Q4 2007 Earnings Call Transcript
Tue February 19, 2008
More transcripts on FVRL »
Sentiment
What advice would you give to
FVRL?
123 characters left
What's your view of FVRL?
Make sure you include FVRL
140 characters left
|
Settings